Jeph Herrin

1. Comparative Effectiveness of Individual DPP-4 Inhibitors on Kidney Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: A Target Trial Emulation
   2026/07/16 by Stacey Sklepinski, Jeph Herrin, Joshua J. Neumiller +10 · 1 voice
   Medicine · #Diabetes Treatment and Management #Heart Failure Treatment and Management #Bariatric Surgery and Outcomes #Linagliptin #Saxagliptin #Alogliptin #Sitagliptin #Kidney disease #Type 2 diabetes #Cohort #Lower risk